| Application no. and date | 18867097.0 (espacenet) (Federated) (European Patent Register), 20181012 | | Patent/reg. no. and date | DK/EP 3679141, 20230607 | | Publication date | 20200715 | | Priority no. and date | US 201762572398 P, 20171013, US 201762572403 P, 20171013, US 201862726950 P, 20180904 | | EP pub. no. and date |
EP 3679141 20200715 | | Effective date | | | Applicant/owner | Novo Nordisk Health Care AG,
The Circle 32/38
8058 Zürich, CH | | Applicant ref. no. | | | Inventor | BROWN, Bob, D., c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
DUDEK, Henryk, T., c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
SAXENA, Utsav, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
PURSELL, Natalie, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
LAI, Cheng, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
WANG, Weimin, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
STORR, Rachel, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
NAZEF, Naim, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
KIM, Boyoung, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US | | Representative | | | Opponent | | | IPC Class | A61K 31/713 (2006.01) , C12N 15/113 (2010.01) | | Title | METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHA | | Int. application no. | US2018055735 | | Int. publication no. | WO2019075419 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
